|
1
|
Gomez-Rubio P, Zock JP, Rava M, Marquez M,
Sharp L, Hidalgo M, Carrato A, Ilzarbe L, Michalski C, Molero X, et
al: PanGenEU Study Investigators: Reduced risk of pancreatic cancer
associated with asthma and nasal allergies. Gut. 66:314–322. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang JJ, Zhu Y, Xie KL, Peng YP, Tao JQ,
Tang J, Li Z, Xu ZK, Dai CC, Qian ZY, et al: Yin Yang-1 suppresses
invasion and metastasis of pancreatic ductal adenocarcinoma by
downregulating MMP10 in a MUC4/ErbB2/p38/MEF2C-dependent mechanism.
Mol Cancer. 13:1302014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Palagani V, Bozko P, El Khatib M, Belahmer
H, Giese N, Sipos B, Malek NP and Plentz RR: Combined inhibition of
Notch and JAK/STAT is superior to monotherapies and impairs
pancreatic cancer progression. Carcinogenesis. 35:859–866. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tactacan CM, Phua YW, Liu L, Zhang L,
Humphrey ES, Cowley M, Pinese M, Biankin AV and Daly RJ: The
pseudokinase SgK223 promotes invasion of pancreatic ductal
epithelial cells through JAK1/Stat3 signaling. Mol Cancer.
14:1392015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gruber R, Panayiotou R, Nye E,
Spencer-Dene B, Stamp G and Behrens A: YAP1 and TAZ control
pancreatic cancer initiation in mice by direct up-regulation of
JAK-STAT3 signaling. Gastroenterology. 151:526–539. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kang M, Ren MP, Zhao L, Li CP and Deng MM:
miR-485-5p acts as a negative regulator in gastric cancer
progression by targeting flotillin-1. Am J Transl Res. 7:2212–2222.
2015.PubMed/NCBI
|
|
8
|
Song X, Wang Z, Jin Y, Wang Y and Duan W:
Loss of miR-532-5p in vitro promotes cell proliferation and
metastasis by influencing CXCL2 expression in HCC. Am J Transl Res.
7:2254–2261. 2015.PubMed/NCBI
|
|
9
|
Huang K, Dong X, Sui C, Hu D, Xiong T,
Liao S and Zhang H: MiR-223 suppresses endometrial carcinoma cells
proliferation by targeting IGF-1R. Am J Transl Res. 6:841–849.
2014.PubMed/NCBI
|
|
10
|
Wu D, Chen B, Cui F, He X, Wang W and Wang
M: Hypoxia-induced microRNA-301b regulates apoptosis by targeting
Bim in lung cancer. Cell Prolif. 49:476–483. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sun Y, Zhao J, Yin X, Yuan X, Guo J and Bi
J: miR-297 acts as an oncogene by targeting GPC5 in lung
adenocarcinoma. Cell Prolif. 49:636–643. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hu S, Zhang M, Sun F, Ren L, He X, Hua J
and Peng S: miR-375 controls porcine pancreatic stem cell fate by
targeting 3-phosphoinositide-dependent protein kinase-1 (Pdk1).
Cell Prolif. 49:395–406. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ahmad A, Sethi S, Chen W, Ali-Fehmi R,
Mittal S and Sarkar FH: Up-regulation of microRNA-10b is associated
with the development of breast cancer brain metastasis. Am J Transl
Res. 6:384–390. 2014.PubMed/NCBI
|
|
14
|
Li P, Xue WJ, Feng Y and Mao QS:
MicroRNA-205 functions as a tumor suppressor in colorectal cancer
by targeting cAMP responsive element binding protein 1 (CREB1). Am
J Transl Res. 7:2053–2059. 2015.PubMed/NCBI
|
|
15
|
Gao Y, Xue Q, Wang D, Du M, Zhang Y and
Gao S: miR-873 induces lung adenocarcinoma cell proliferation and
migration by targeting SRCIN1. Am J Transl Res. 7:2519–2526.
2015.PubMed/NCBI
|
|
16
|
Shan TD, Ouyang H, Yu T, Li JY, Huang CZ,
Yang HS, Zhong W, Xia ZS and Chen QK: miRNA-30e regulates abnormal
differentiation of small intestinal epithelial cells in diabetic
mice by downregulating Dll4 expression. Cell Prolif. 49:102–114.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Huang X, Huang M, Kong L and Li Y: miR-372
suppresses tumour proliferation and invasion by targeting IGF2BP1
in renal cell carcinoma. Cell Prolif. 48:593–599. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang XW, Shen GZ, Cao LQ, Jiang XF, Peng
HP, Shen G, Chen D and Xue P: MicroRNA-1269 promotes proliferation
in human hepatocellular carcinoma via downregulation of FOXO1. BMC
Cancer. 14:9092014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Png KJ, Yoshida M, Zhang XH, Shu W, Lee H,
Rimner A, Chan TA, Comen E, Andrade VP, Kim SW, et al: MicroRNA-335
inhibits tumor reinitiation and is silenced through genetic and
epigenetic mechanisms in human breast cancer. Genes Dev.
25:226–231. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gao X and Jin W: The emerging role of
tumor-suppressive microRNA-218 in targeting glioblastoma stemness.
Cancer Lett. 353:25–31. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jiang J, Zhang Y, Yu C, Li Z, Pan Y and
Sun C: MicroRNA-492 expression promotes the progression of hepatic
cancer by targeting PTEN. Cancer Cell Int. 14:952014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Denoyelle C, Lambert B, Meryet-Figuière M,
Vigneron N, Brotin E, Lecerf C, Abeilard E, Giffard F, Louis MH,
Gauduchon P, et al: miR-491-5p-induced apoptosis in ovarian
carcinoma depends on the direct inhibition of both BCL-XL and EGFR
leading to BIM activation. Cell Death Dis. 5:e14452014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yonemori K, Kurahara H, Maemura K and
Natsugoe S: MicroRNA in pancreatic cancer. J Hum Genet. 62:33–40.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lv Y, Lei Y, Hu Y, Ding W, Zhang C and
Fang C: miR-448 negatively regulates ovarian cancer cell growth and
metastasis by targeting CXCL12. Clin Transl Oncol. 17:903–909.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li QQ, Chen ZQ, Cao XX, Xu JD, Xu JW, Chen
YY, Wang WJ, Chen Q, Tang F, Liu XP, et al: Involvement of
NF-κB/miR-448 regulatory feedback loop in chemotherapy-induced
epithelial-mesenchymal transition of breast cancer cells. Cell
Death Differ. 18:16–25. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wu X, Tang H, Liu G, Wang H, Shu J and Sun
F: miR-448 suppressed gastric cancer proliferation and invasion by
regulating ADAM10. Tumour Biol. 37:10545–10551. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li B, Ge L, Li M, Wang L and Li Z: miR-448
suppresses proliferation and invasion by regulating IGF1R in
colorectal cancer cells. Am J Transl Res. 8:3013–3022.
2016.PubMed/NCBI
|
|
28
|
Shen L, Liu L, Ge L, Xie L, Liu S, Sang L,
Zhan T and Li H: miR-448 downregulates MPPED2 to promote cancer
proliferation and inhibit apoptosis in oral squamous cell
carcinoma. Exp Ther Med. 12:2747–2752. 2016.PubMed/NCBI
|
|
29
|
Zhu H, Zhou X, Ma C, Chang H, Li H, Liu F
and Lu J: Low expression of miR-448 induces EMT and promotes
invasion by regulating ROCK2 in hepatocellular carcinoma. Cell
Physiol Biochem. 36:487–498. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mendonsa AM, VanSaun MN, Ustione A, Piston
DW, Fingleton BM and Gorden DL: Host and tumor derived MMP13
regulate extravasation and establishment of colorectal metastases
in the liver. Mol Cancer. 14:492015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Guschin D, Rogers N, Briscoe J, Witthuhn
B, Watling D, Horn F, Pellegrini S, Yasukawa K, Heinrich P, Stark
GR, et al: A major role for the protein tyrosine kinase JAK1 in the
JAK/STAT signal transduction pathway in response to interleukin-6.
EMBO J. 14:1421–1429. 1995.PubMed/NCBI
|
|
32
|
Verma A, Kambhampati S, Parmar S and
Platanias LC: Jak family of kinases in cancer. Cancer Metastasis
Rev. 22:423–434. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yuan J, Ji H, Xiao F, Lin Z, Zhao X, Wang
Z, Zhao J and Lu J: MicroRNA-340 inhibits the proliferation and
invasion of hepatocellular carcinoma cells by targeting JAK1.
Biochem Biophys Res Commun. 483:578–584. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liu D, Huang Y, Zeng J, Chen B, Huang N,
Guo N, Liu L, Xu H, Mo X and Li W: Down-regulation of JAK1 by RNA
interference inhibits growth of the lung cancer cell line A549 and
interferes with the PI3K/mTOR pathway. J Cancer Res Clin Oncol.
137:1629–1640. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xiong H, Zhang ZG, Tian XQ, Sun DF, Liang
QC, Zhang YJ, Lu R, Chen YX and Fang JY: Inhibition of JAK1,
2/STAT3 signaling induces apoptosis, cell cycle arrest, and reduces
tumor cell invasion in colorectal cancer cells. Neoplasia.
10:287–297. 2008. View Article : Google Scholar : PubMed/NCBI
|
